SeraCare Team: Board of Directors

Joe Bernardo – Chairman of the Board

Joe Bernardo joined the SeraCare board of directors as chairman of the board in early 2018. He is currently the lead Operating Partner supporting Linden Capital Partners’ diagnostics and life science tools efforts. He is a veteran diagnostics executive who spent over 25 years with premier diagnostics organizations such as Thermo Fisher Scientific, Siemens Healthcare, and Abbott Laboratories. He took on the role of President of the Next-Generation Sequencing and Oncology division in 2015 and was responsible for leading Thermo Fisher’s efforts in these businesses, as well as his team which supported the development of innovative NGS-based solutions for other businesses within Thermo Fisher Scientific. He holds a Bachelor of Science in Chemistry from Lafayette College and a Master of Arts in Chemistry from the University of Virginia.

Brian Miller – Director

Brian Miller is a Managing Partner and Co-Founder of Linden Capital Partners. He has been involved in principal investing and investment banking since 1996. Prior to Linden, Brian was a founding member of the healthcare team at First Chicago Equity Capital. Mr. Miller began his career in the investment banking division of Salomon Brothers Inc. (currently Citigroup). He is currently a board member of AdvaMed, AdvaMedDx, The Flexan Corporation, The HydraFacial Company, MeriCal, SeraCare, Solara, and Z-Medica, and was previously a board member of BarrierSafe Solutions International, CORPAK MedSystems, HYCOR Biomedical, Strata Pathology Services and Suture Express. Mr. Miller holds a Bachelor of Arts with honors in Economics from Princeton University and an MBA from Harvard Business School, with a concentration in healthcare. He is the Founder and Chairman of the Healthcare Private Equity Association, the founder of Private Equity Analysts of Chicago, a Trustee of the Latin School of Chicago, and a member of the Economic Club of Chicago.

Charlie Mamrak – Director

Charlie Mamrak joined SeraCare as CEO and director of the board when the Chicago-based private equity firm, Linden Capital Partners, acquired the company in 2012. Before assuming his current role, Mr. Mamrak was an operating partner at Linden where he focused on building the firm’s investment portfolio in life sciences and diagnostics. Prior to Linden, he was CEO of TestPak and then PML MicroBiologicals. Mr. Mamrak has also held general management posts at Fisher Scientific and Sigma-Aldrich in life science research and drug discovery. He has experience progressing from bench level to laboratory and operations management at contract research laboratories including DuPont and Corning. Mr. Mamrak studied biomedical engineering at Pennsylvania State University and earned his BS in biology and chemistry from Moravian College.

Francis J. Lunger – Director

Francis Lunger served as chairman of the board of directors of SeraCare from 2012 through the end of 2017. He has also been on the board of directors of Dentsply International since 2005. Mr. Lunger has a wealth of experience in the technology, life science, medical device, and manufacturing sectors. Prior to chairing SeraCare’s board, he held several senior leadership and executive management positions at Millipore - most notably as CEO and chairman of the board. Mr. Lunger was an operating partner with Linden Capital Partners and has held executive management positions at Oak Industries, Inc., Nashua Corporation, Raychem Corporation, and Baxter International.

Daniel Tereau – Director

Daniel Tereau has served on SeraCare’s board since 2012 and is currently the global vice president of strategy and business development for PerkinElmer. His executive experience includes being a member of Novartis’ consumer health division leadership team, as well as similar roles at Thermo Fisher Scientific and GE Healthcare. Mr. Tereau also has experience working in finance and marketing at PepsiCo and General Motors. He earned his BS in finance from Ferris State University, his JD from Wayne State University, and his MBA from Yale University, where he attended as a Sloan Fellow.

Nick Roelofs, PhD – Director

Nick Roelofs has been on SeraCare’s board of directors since 2014. He is an industrial advisor at Nordic Capital, Ltd. and serves on the boards of several other companies. Dr. Roelofs has over 20 years of experience in the life sciences and diagnostics industries, including senior leadership and executive management positions at Agilent Technologies, Bio-Rad, Stratagene, Inc., and Applied Biosystems. He earned his PhD in organic chemistry from the University of Nevada, Reno and his MS in organic chemistry from the University of Iowa.